Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06053333 · ClinicalTrials.gov registry record
Social Determinants of Health in Hepatobiliary Cancer Patients
A clinical trial of Malignant Hepatobiliary Neoplasm, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT06053333: Recruiting study of Malignant Hepatobiliary Neoplasm, sponsored by Mayo Clinic.
NCT06053333 is a study of Malignant Hepatobiliary Neoplasm that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 400 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06053333, a study of Malignant Hepatobiliary Neoplasm, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates barriers to receiving care and risks associated with developing cancer among patients diagnosed with hepatobiliary cancer.
Primary Outcome
Estimated using Social Determinants of Health Screening Tool designed by the American Academy of Family Medicine, by the proportion of patients who respond "yes" to the question, "Do you put off or neglect going to the doctor because of distance or transportation?".
Conditions Studied
Interventions
- OTHER Non-Interventional Study
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2023-07-17 |
| Est. Completion | 2028-07-17 |
What NCT06053333 shows while recruiting
NCT06053333 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Malignant Hepatobiliary Neoplasm appearing as the primary indexed condition, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT06053333 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06053333 about?
NCT06053333 is a clinical study titled "Social Determinants of Health in Hepatobiliary Cancer Patients". This study evaluates barriers to receiving care and risks associated with developing cancer among patients diagnosed with hepatobiliary cancer.
What is the current status of trial NCT06053333?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2023-07-17. Estimated completion is 2028-07-17.
What conditions does trial NCT06053333 study?
This clinical trial studies the following conditions: Malignant Hepatobiliary Neoplasm.
What interventions are being tested in trial NCT06053333?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT06053333?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06053333 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Hepatobiliary Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI